Abstract
INTRODUCTION
Spine is the most common site of bone metastases. Knowledge of survival of the individual can help predict the subsequent disease course. Patients with a predicted survival of 3 to 6 months may not be suitable candidates for surgical intervention. [2] There are multiple scoring systems that have been devised to help determine patient survival in order to guide treatment options. [2] This study attempted to determine the effectiveness of the modified Bauer [ Table 1 ], Tomita [ Table 2 ], modified Tokouhashi [ Table 3 ], Spinal Instability Neoplastic Score (SINS) [ Table 4 ] scoring systems for predicting prognosis in patients with metastases of spine.
MATERIALS AND METHODS

Database of 63 patients
We prospectively collected data and outcomes for 63 patients with spinal metastasis who underwent surgery between 2005 and 2016. Patients, averaging 53.73 years of age, were followed for an average of 18 months (range 1-72 months), with a minimum follow-up of 6 months. Spinal metastasis were located in the cervical spine (8 patients), dorsal spine (30 patients), lumbar spine (20 patients), and sacrum (two patients). Multiple regions were involved in three patients. The most common types of primary malignancy were breast (13 patients) and lung cancers (11 patients) . In 14 patients, the primary site was unidentified, of which 6 were labeled as adenocarcinomas [ Table 5 ]. There were 38 patients who underwent palliative excision, while others were treated with complete excision and decompression for attempted cure. Notably, 38 patients expired during the course of this study. Common symptoms and their frequency is elicited in Figure 1 .
Preoperative radiographic assessment
All patients were evaluated pre operatively with plain radiographs, computed tomography (CT), and magnetic resonance imaging of the spine. Bone scintigraphy and a CT of the chest and abdomen were also performed to evaluate the extent of systemic metastases. Patients were selected for surgery based on: (i) expected survival of more than 6 months, (ii) exacerbating pain, (iii) presence 
Statistical analysis
Data was examined using survival analysis. As the survival data was not uniformly distributed, the median duration of survival and its 95% confidence interval (CI) were used. Survival curves were estimated by means of the Kaplan-Meier methods. The predictive value of each scoring system was evaluated by using log-rank test. A P value of <0.050 was considered statistically significant. The log-rank test and Cox proportional hazards model were utilized to determine factor-influenced progression.
RESULTS
Survival analysis of each preoperative factor utilized the log rank test [ Table 6 ]. Age (P = 0.008) and pre-operative neurological status (P = 0.016) depicted a statistically significant relationship to survival. Younger age and good neurological status (Frankel grade C-E) were associated with prolonged survival. While variables like gender, spinal region, and type of surgical approach did not affect survival rates.
The Tokuhashi, Tomita, and Bauer scores provided statistically significant results, while those for SINS were not significant. The Tomita Score provided the highest statistical significance (P = 0.000) followed by the Bauer (P = 0.002) and Tokuhashi (P = 0.003) scores [ Tables 7, 8 and Figures 2 -5] . Since the numbers of individual neoplasms in each category of scores were of neurological deficits, and (iv) instability. The authors studied multiple preoperative variables: age, gender, the type of primary malignancy, symptoms and their duration, the involved spinal level, neurological status, and the type of surgical procedure offered. Thyroid  0  2  1  1  0  1  1  0  0  2  Unidentified  5  9  11  3  3  8  3  0  0  14  Upper Git  0  2  2  0  0  0  1  0  1  2  Urothelial  0  1  0  1  0  0  1  0  0  1  Lung  1  10  10  1  0  8  2  1  0  11  Total  21  42  40  23  8  30  20  2  3  63 Multiple: Lumbar and dosral to have the worst prognosis, with a mean survival rate of only 5.81 months. [ Tables 9 and 10 ].
DISCUSSION
Estimating life expectancy in patients afflicted with spinal metastases is important. Management requires small, individual calculation of P value for the same was not possible.
Survival
The mean survival period was recorded according to the primary malignancy; breast correlated with a mean survival of 38.6 months, followed by prostate (26.33 months), and thyroid (21 months). Lung primaries were reported a multidisciplinary approach utilizing multimodality treatments options to address spinal metastases. It is important to evaluate these patients based upon universally accepted scientific criteria that can be replicable. Various prognostic scoring systems have been recommended [12] and used by the Global Spinal Tumor Study Group [ Tables 1-4 ]. [6, 10] Various surgical procedures can be performed in patients with spinal metastasis. Surgery should be reserved for patients with good or moderate prognosis, but not for prognoses of less than 3-6 months. [5, 11] The metastatic potential, invasive ability, rate of recurrence, and sensitivity to adjuvant treatment varies with different types of cancers. The primary tumor site is the most important prognostic factor for survival. [7] [8] [9] [10] This major factor is well reflected by the allotment of maximum scoring points in the Tokouhashi revised score (0-5), [8] as well as Tomita and Bauer. [7, 9] In Bauer's score, of the four parameters, two are based on the primary tumor site. [7] Metastases of the spine can cause significant instability, resulting in severe pain, progressive deformity and/or neurological compromise. SINS classification identifies patients with impending or existing spinal instability, for whom surgical intervention may be beneficial; [4] 60% of our study population were 'potentially stable' indicating the marked extent of involvement of vertebral column with metastatic disease.
Tokuhashi et al. designed a scoring system based on 6 prognostic factors, whereas the Tomita system was based on three simple factors: the grade of the primary malignancy, the presence of visceral metastases, and the Tokuhashi   0-8   Total  2  2  3  0  1  1  1  0  1  1  0  0  14  2  0  11   Mean  15  17  8  --------- presence of bone metastases. In both scoring systems, the type or grade of the primary malignancy is the most important factor affecting survival. [6, 8] The Bauer original and modified scores were the most independent scoring systems, showing significant distinction between the proposed prognostic groups, and the strongest impact on predicting the remaining survival in patients with spinal metastases. [3] In our study, four prognostic scoring systems were compared in patients with spinal metastases. The Bauer and Tomita scoring systems have showed statistical significance in predicting survival vs. the other scores. [1] Notably, the Tokuhashi score is more complicated and includes many other variables, and thus results in decreased predictive reliability. [4] The simpler scores (Tomita and modified Bauer) have more reliable results. [1] Our study showed that Tomita had the least P value (P value = 0.00), and the modified Bauer (P value = 0.002) was a simple and universally applicable prognostic system. SINS had a minimal role in predicting the overall survival and was considered as an add-on support in providing insights to the need of fusion [ Figures 6 and 7] .
Analysis of our study showed that breast lesions were most common followed by lung. Like many other series, lung cancer showed the worst prognosis. [5] Age and preoperative neurology showed correlation with survival. Independent preoperative variables including gender, region, symptom duration, pain severity, and surgical approach did not have an effect on the post-operative survival.
CONCLUSION
Of the four widely used scores to assess the extent of metastatic disease to the spine, the Tomita, the modified Tokouhashi and the Bauer, demonstrated statistically significant predictive results. Alternatively, the SINS scoring system, though a good indicator for choosing patients for surgery, lacked statistical significance in predicting survival.
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